Abstract
Cyanobacteria produce structurally and functionally diverse polyketides, nonribosomal peptides and their hybrids. Sfp-type phosphopantetheinyl transferases (PPTases) are essential to the production of these compounds via functionalizing carrier proteins (CPs) of biosynthetic megaenzymes. However, cyanobacterial Sfp-type PPTases remain poorly characterized, posing a significant barrier to the exploitation of cyanobacteria for biotechnological and biomedical applications. Herein, we describe the detailed characterization of multiple cyanobacterial Sfp-type PPTases that were rationally selected. Biochemical characterization of these enzymes along with the prototypic enzyme Sfp from Bacillus subtilis demonstrated their varying specificities toward 11 recombinant CPs of different types of biosynthetic pathways from cyanobacterial and Streptomyces strains. Kinetic analysis further indicated that PPTases possess the higher binding affinity and catalytic efficiency toward their cognate CPs in comparison with noncognate substrates. Moreover, when chromosomally replacing the native PPTase gene of Synechocystis sp. PCC6803, two selected cyanobacterial PPTases and Sfp supported the growth of resulted mutants. Cell lysates of the cyanobacterial mutants further functionalized recombinant CP substrates. Collectively, these studies reveal the versatile catalysis of selected cyanobacterial PPTases and provide new tools to synthesize cyanobacterial natural products using in vitro and in vivo synthetic biology approaches.
Introduction
More than 1,000 structurally diverse natural products have been isolated from cyanobacterial species over the past decades1,2. These compounds possess a wide array of bioactivities, e.g., antibacterial, antifungal, antiviral, immunomodulatory, protease inhibitory, and cytotoxic activities3–5. Evidently, monomethyl auristatin E, a derivative of cyanobacterial nonribosomal peptide/polyketide (NRP/PK) hybrid dolastatin 106,7, is a clinically valuable anti-mitotic agent. Remarkably, bioinformatic analysis of over 140 cyanobacterial genomes available in the NCBI database reveals at least three NRP synthetases (NRPSs) per genome on average, while some genomes contain more than forty natural product gene clusters8,9. These results illustrate the untapped potential of cyanobacteria as a source of new chemicals. However, this potential remains unachievable unless capable tools are available to translate cyanobacterial genetic information into compounds10,11. Indeed, only a few cyanobacterial natural products including several ribosomally synthesized and post-translationally modified peptides12,13, barbamide (a PK/NRP hybrid) and lyngbyatoxin A (an NRP) have so far been heterologously produced in E. coli or Streptomyces sp.14–16. Recently, lyngbyatoxin A was also produced in the model cyanobacterium Anabaena sp. PCC7120, achieving a yield similar to its native producer Moorea producens 17.
Phosphopantetheinyl transferases (PPTases) play an essential role in the biosynthesis of fatty acids (FAs), NRPs, and PKs by functionalizing carrier protein (CPs) of their corresponding biosynthetic enzymes. They use coenzyme A (CoA) as one substrate to posttranslationally modify one conserved serine residue of the CPs with a 4′-phosphopantetheine (PPant) moiety, thereby converting inactive apo-form CPs to active holo-form proteins (Fig. S1)18. The CPs are responsible for shuttling biosynthetic intermediates among multiple catalytic domains within a module and delivering the substrate to the next module via the PPant arm. Based on sequence simila-rity and substrate specificity, PPTases are categorized into three subfamilies19. AcpS from E. coli is the prototype of the first subfamily20, whose members generally comprise about 120 amino acids and functionalize only the CPs of FA synthases (FASs). The second subfamily of PPTases comprises integrated domains within the type I yeast and fungal FASs, where they specifically modify the cognate CPs19. The last subfamily is known as Sfp-type PPTases, named after the archetypal enzyme Sfp from Bacillus subtilis 21. Compared to AcpSs, these enzymes are two times longer and functionalize a broad range of substrates including noncognate CPs for the biosynthesis of FAs, NRPs, PKs, and their hybrids21. Sfp-type PPTases can further be subdivided into the NRPS-preferred F/KES and PKS-favored W/KEA groups based on their sequences22. Given their attractive substrate promiscuity, Sfp-type PPTases have demonstrated many biotechnological applications, including site-specific protein labeling, cell imaging, and the heterologous production of microbial secondary metabolites23–25.
Despite the attractive potential of cyanobacterial natural products, only three PPTases from cyanobacteria have so far been biochemically characterized17,26,27. The enzyme from the cyanobacterium Nodularia spumigena NSOR10 (NsPPT) is the only one activating both cognate and noncognate CPs of cyanobacteria26,27. Synechocystis sp. PCC6803 (hereafter referred to as Synechocystis) encodes only one PPTase (SPPT) and this enzyme was shown to activate only the CP of its cognate FAS27. In addition, biochemical characterization of the PPTase from Oscillatoria PCC6506 (OPPT) was performed with one cognate CP28. On the other hand, the E. coli BAP1 strain carrying a chromosomal Sfp gene is able to produce several functional cyanobacterial FASs, PK synthases (PKSs) and NRPSs29–31, indirectly suggesting the versatility of Sfp in activating cyanobacterial CPs. Here, we report the characterization of six cyanobacterial PPTases and Sfp toward 11 CPs of known and silent pathways from cyanobacteria and Streptomyces strains. Biochemical and kinetic studies indicated the varying substrate promiscuity of these enzymes and suggested the coevolution of PPTases/cognate CP substrates. Two selected cyanobacterial PPTases and Sfp further demonstrated the versatile in vivo and in vitro catalytic activity when they were transiently expressed in Synechocystis. These results identify cyanobacterial PPTases with the catalytic proficiency and efficiency in activating CPs from diverse natural product biosynthetic pathways and lay a solid foundation to harness the biosynthetic potential of cyanobacteria via synthetic biology approaches.
Materials and Methods
Phylogenetic analysis of cyanobacterial PPTases
Sfp and E. coli AcpS were used as two query sequences to mine currently available cyanobacterial genomes in NCBI database (up to Nov 1st, 2016) using BLAST program. The output data of BLAST were carefully analyzed to identify the sequences with comparatively high similarity (with e-values ≤10–5) and to eliminate redundant sequences from taxonomically close species. The resulted selection of 39 PPTase protein sequences along with those from Streptomyces rapamycinicus NRRL5491, Xenopus laevis and Homo sapiens was aligned by Clustal Omega and then analyzed with MEGA732 using a maxi-mum likelihood statistical method to construct a phylogenetic tree. The confidence was evaluated with 1000 bootstraps.
Biochemical characterization of PPTase activity
Enzyme reaction solutions (100 μl) typically contained 50 mM Tris-Cl, pH 8.0, 12.5 mM MgCl2, 0.5 mM coenzyme A, 5 mM dithiothreitol (DTT) and 50 μM CPs. The reactions were initiated by adding 0.3 μM (final concentration) of PPTases, incubated at 37 °C for 20 min, and terminated by mixing with 100 μl of 10% formic acid. To quantitatively determine the relative activity of the enzymes, the reaction time can be up to 40 min. The quenched solutions were centrifuged at 4 °C, 16,000 × g for 15 min and clear supernatants were collected and subjected to HPLC and LCMS analysis with details shown in the supporting information. All experiments were repeated in triplicate. For kinetic studies, the reactions were set up as described above except that the concentrations of CPs were varied from 0.5 to 120 μM. The reactions were performed at 37 °C for 5-10 min to ensure that ≤10% of substrates were converted. To determine the concentrations of holo-CPs, 0.2 to 50 μM of apo-proteins were fully converted in the enzyme reactions and then quantitated in HPLC analysis to establish standard curves of holo-CPs. The concentrations of existing holo-CPs in the substrate solutions were subtracted in the data analysis. Data were fit into the Michaelis-Menten equation to determine kinetic parameters using GraphPad Prism 4.0. All experiments were independently repeated three times.
Genetic engineering of Synechocystis
Synechocystis cells (about 1 × 108 cells/ml) in the exponential phase were collected after centrifugation at 8,000 rpm for 15 min and resuspended in fresh BG11 medium at a density of 1 × 109 cells/ml. Integration constructs at a final concentration of 10 μg/ml were then incubated with the cell solution at room temperature. After 5 h, the mixtures were spread onto BG11 agar plates supplemented with 5 μg/ml kanamycin. The segregation of wild type with the desirable mutants was achieved by iteratively streaking the colonies onto plates with progressively increased concentrations of kanamycin (up to 50 μg/ml). The final stable mutants were genotyped by the colony PCR using the primers listed in Table S1. Growth curves of the wild type and three mutant strains were determined by daily record of the OD730 of the liquid cultures over the period of 13 days.
Quantitative RT-PCR analysis of the integrated exogenous PPTase genes
Total RNA samples were isolated from Synechocystis and its mutants using ZR Fungal/Bacterial RNA MiniPrep kit (Zymo Research). The quantity and quality of the isolated RNAs were determined using Nanodrop. Synthesis of cDNAs was performed with random primers following the manufacturer’s protocol (Thermo Scientific). The synthesized cDNAs were used as templates for qPCR to detect the transcription of the integrated PPTase genes, while the isolated RNA samples themselves were used as the templates of PCR reactions to detect any residual genomic DNAs using primers listed in Table S1. The student’s t-test analysis was applied to determine significance difference between the samples, and a P-value < 0.05 was considered to be statistically significant.
Preparation of cell lysates of Synechocystis mutants
Cells of the wild type and three Synechocystis mutants were harvested from 0.8 to 1.0 L culture after centrifugation at 4 °C, 4,000 × g for 15 min. Cell pellets were washed with fresh BG11 medium and then resuspended in 4 ml of lysis buffer (50 mM MES, pH 7.0, 10 mM MgCl2, 5 mM CaCl2, 1 mM phenylmethylsulfonyl fluoride and 10% glycerol). The solutions were frozen at −80 °C and thawed at room temperature prior to the sonication on ice with 2-s pulses. Cell homogenates were centrifuged at 4 °C, 25,000 × g for 30 min to collect clear cell lysates. The enzyme reaction mixtures were set up as described above except containing 70 μl of cell lysates. The reactions were incubated at 37 °C for 16 h, and the holo-products were detected in LCMS analysis as described above. The reactions were performed in triplicate.
Data availability statement
All data generated or analyzed during this study are included in this manuscript (and its Supplementary Information files).
Results and Discussion
Phylogenetic analysis of cyanobacterial Sfp-type PPTases
To gain an understanding of the evolutionary relationship of cyanobacterial PPTases, we mined all cyanobacterial genomes available in NCBI database using Sfp and E. coli AcpS as queries. A total of 39 sequences was then selected and retrieved from 39 strains of 26 genera that broadly cover all five subsections of cyanobacteria (Table S2)33. Phylogenetic analysis of these sequences led to a constructed tree comprising an AcpS-type clade, which included AcpS and eight cyanobacterial PPTases, and a Sfp-type clade containing all other enzymes (Fig. 1)19. In the Sfp-type clade, Sfp and three PPTases from Streptomyces rapamycinicus NRRL5491, Xenopus laevis and Homo sapiens as outgroups were separated from cyanobacterial Sfp-type PPTases. Furthermore, enzymes from the heterocystous cyanobacteria (subsections IV and V) formed a sub-clade, while those from sections I-III showed a less clear pattern. For example, the PPTases from Gloeocapsa sp. PCC73106 (subsection I) and Spirulina subsalsa (subsection III) fell into the same group (Fig. 1). These results indicate that cyanobacterial Sfp-type PPTases share a common ancestor and have acquired different traits over the course of evolution.
Selection of cyanobacterial Sfp-type PPTases and CP substrates
To comprehensively understand the catalytic performance of cyanobacterial Sfp-type PPTases, we next selected representative enzymes based on the result of phylogenetic analysis (Fig. 1) and predicted biosynthetic potential of cyanobacterial strains. The genomes of Fischerella sp. PCC9339 (hereafter Fischerella), Anabaena sp. PCC7120 (hereafter Anabaena) and A. variabilis ATCC29413 all possess more than 10 NRP and/or PK gene clusters13 and their PPTases, FPPT, APPT and AvPPT, respectively, were included in this work due to potentially broad substrate promiscuity. In addition, FPPT and APPT/AvPPT belong to two distantly related groups in the same subclade of subsections IV and V, likely representing the enzymes from a variety of heterocystous cyanobacteria (Fig. 1). We also selected the PPTases from Microcystis aeruginosa NIES843 (MPPT) carrying a rich biosynthetic potential34 and Synechococcus elongatus PCC7942 (SePPT) that forms a separate leaf in the phylogenetic tree (Fig. 1). S. elongatus PCC7942 encodes no PK or NRP cluster. Furthermore, SPPT was included as a control due to its reported narrow substrate scope27. Finally, the paucity of biochemical characterization of Sfp in activating cyanobacterial CPs led to its selection. The six selected cyanobacterial PPTases and Sfp contain the featured W/KEA motif22 (Fig. S2) and together cover the broad space of the constructed phylogenetic tree (Fig. 1).
We next chose 11 CPs from multiple biosynthetic pathways of different species for biochemical characterization of the selected PPTases (Table S3, Fig. S3). They included two ACPs of FASs from Synechocystis (SFACP) and Anabaena (AFACP), one ACP of the glycolipid PKS in Anabaena (APACP)35, one ACP of the apratoxin (PK/NRP) gene cluster in Lyngbya (Moorea) bouillonii (AprACP), and the PCP of the shinorine gene cluster from Fischerella 36. In addition, we included three CPs of uncharacterized gene clusters from Fischerella (FNPCP, an NRP pathway), Anabaena (APNPCP, an NRP/PK pathway) and M. aeruginosa NIES843 (MACP, an NRP/PK pathway) and one ACP from Fischerella (FNsACP) that is a homologous enzyme of previously characterized ArCPNp 26. To thoroughly examine the versatility of selected PPTases, we also included one ACP of a putative concanamycin gene cluster from Streptomyces coelicolor A(3)2 (ScACP) and one PCP of a thaxtomin cluster from the plant pathogen S. scabiei 87.22 (SsPCP)37.
In vitro Phosphopantetheinylation of cognate and noncognate CPs by selected PPTases
Recombinant proteins (Fig. S3) were purified from E. coli by a single step Ni-NTA affinity chromatography. All purified proteins showed expected molecular weights in SDS-PAGE analysis (Fig. S4), and the CP substrates were further validated in LC-MS analysis. SFACP, AFACP and SsPCP gave rise to two peaks in the LC traces with the minor peaks as the holo-proteins (Fig. 2A). The rest of CP substrates were in the apo-form (Fig. 2B, Table S3, and Fig. S5). This result suggests that E. coli AcpS activates noncognate ACPs of FASs to a low level and shows the limited promiscuity toward CPs of NPRSs and PKSs.
We next examined the catalytic activity of each PPTase toward all 11 recombinant CPs. The substrates in 69 out of all 77 reactions were fully converted into the holo-products (Figs 2 and 3). APPT, AvPPT, MPPT and Sfp functionalized all substrates (Table S4). Unexpectedly, SPPT also phosphopantetheinylated all CP substrates except ScACP (Fig. 3, and Table S3). In an early report, SPPT was unable to activate two ACPs from Nostoc punctiforme ATCC 29133 and one PCP from M. aeruginosa PCC780627. On the other hand, SePPT and FPPT showed no activity toward APNPCP, MACP and ScACP and the former was also inactive toward SsPCP.
To quantitate the substrate preference of PPTases, the reactions were performed to allow less than 95% of substrate conversion. After setting the activity of the most active enzyme as 100%, the activities of other PPTases toward the same substrate were normalized (Fig. 3, and Table S4). By this analysis, APPT showed the highest conversion rates toward seven cyanobacterial CPs from the FA, PK, NRP, and PK/NRP biosynthetic pathways. APPT also activated ScACP and SsPCP from Streptomyces species with relative activities of 64.9% and 28.8%, respectively, demonstrating a broad-range substrate scope. In line with the observed substrate flexibility, APPT has functionalized the ACP of microalgal polyunsaturated fatty acid synthase in canola38 and allowed the hetero-logous production of lyngbyatoxin A in Anabaena 17. AvPPT possessed a similar substrate scope and comparable activities to APPT. We also observed the high activity and versatility of MPPT and SPPT. MPPT showed more than 84% relative activities toward all nine cyanobacterial CPs and a modest relative activity toward ScACP (18.8%) and SsPCP (24%), while SPPT promoted more than 71% relative conversions of eight cyanobacterial CPs. Similar to the above four cyanobacterial PPTases, Sfp functionalized seven cyanobacterial CPs (25.1% to 99.6%) to comparable levels of APPT and showed the highest relative activities toward ScACP and SsPCP. By contrast, SePPT and FPPT in general showed lower relative activities in functionalizing 7 and 8 selected CPs, respectively. Collectively, the results of biochemical studies provide the first comprehensive evaluation of cyanobacterial PPTases in terms of enzymatic activity and substrate scope.
Kinetic analysis of APPT, MPPT, SPPT and Sfp
To assess the catalytic efficiency of selected PPTases, we kinetically analyzed APPT, MPPT, SPPT and Sfp in activating all 11 CP substrates (Table 1, and Fig. S6). The conversion of SsPCP by Sfp showed the highest catalytic efficiency (k cat/K m = 2.1 ± 0.2 µM−1 min−1) of all reactions, consistent with the overall kinetic performance of Sfp toward CPs of actinomycetes21,39. On the other hand, the catalytic efficiencies (k cat/K m) of Sfp toward nine cyanobacterial CPs were varied from 0.1 ± 0.02 µM−1 min−1 (FisPCP) to 1.5 ± 0.3 µM−1 min−1 (APACP).
Table 1.
Substrate | APPT | MPPT | SPPT | Sfp | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
K m b | k cat b | k cat/K m b | K m | k cat | k cat/K m | K m | k cat | k cat/K m | K m | k cat | k cat/K m | |
SFACP | 2.8 ± 0.2 | 1.6 ± 0.09 | 0.6 ± 0.07 | 3.2 ± 0.2 | 1.2 ± 0.1 | 0.4 ± 0.07 | 1.5 ± 0.2 | 1.4 ± 0.1 | 0.9 ± 0.2 | 2.5 ± 0.3 | 2.2 ± 0.1 | 0.9 ± 0.2 |
AFACP | 6.8 ± 0.5 | 11.7 ± 0.5 | 1.7 ± 0.2 | 6.9 ± 0.4 | 8.4 ± 0.2 | 1.2 ± 0.1 | 13.3 ± 1.6 | 14.7 ± 1.1 | 1.1 ± 0.2 | 11.6 ± 0.6 | 9.8 ± 0.3 | 0.8 ± 0.07 |
APACP | 10.0 ± 0.9 | 17.0 ± 0.6 | 1.6 ± 0.2 | 23.1 ± 4.1 | 21.2 ± 1.6 | 0.9 ± 0.2 | 26.5 ± 5.2 | 14.6 ± 1.3 | 0.5 ± 0.1 | 15.3 ± 2.1 | 22.1 ± 1.4 | 1.5 ± 0.3 |
ScACP | 14.1 ± 1.6 | 5.4 ± 0.3 | 0.4 ± 0.07 | 12.4 ± 1.5 | 2.6 ± 0.1 | 0.2 ± 0.04 | N/Ac | N/Ac | N/Ac | 8.3 ± 0.5 | 15.2 ± 0.5 | 1.8 ± 0.1 |
SsPCP | 7.4 ± 0.5 | 7.6 ± 0.2 | 1.0 ± 0.09 | 9.1 ± 0.3 | 7.1 ± 0.1 | 0.7 ± 0.04 | 14.3 ± 1.1 | 1.0 ± 0.04 | 0.06 ± 0.008 | 7.9 ± 0.7 | 16.7 ± 0.7 | 2.1 ± 0.2 |
FNPCP | 12.1 ± 0.5 | 12.2 ± 0.3 | 1.0 ± 0.07 | 7.2 ± 0.7 | 9.6 ± 0.4 | 1.3 ± 0.2 | 7.0 ± 0.6 | 10.1 ± 0.4 | 1.4 ± 0.2 | 11.7 ± 0.8 | 14.5 ± 0.6 | 1.2 ± 0.1 |
FisPCP | 7.1 ± 0.5 | 2.3 ± 0.06 | 0.3 ± 0.03 | 7.2 ± 0.3 | 1.9 ± 0.03 | 0.3 ± 0.02 | 10.0 ± 0.5 | 2.5 ± 0.05 | 0.3 ± 0.02 | 14.0 ± 1.2 | 1.7 ± 0.07 | 0.1 ± 0.02 |
MACP | 7.9 ± 0.9 | 3.7 ± 0.2 | 0.5 ± 0.08 | 4.9 ± 0.3 | 4.2 ± 0.1 | 0.9 ± 0.07 | 22.0 ± 1.6 | 4.3 ± 1.1 | 0.2 ± 0.06 | 6.7 ± 0.7 | 5.1 ± 0.2 | 0.8 ± 0.1 |
APNPCP | 1.6 ± 0.1 | 1.0 ± 0.05 | 0.6 ± 0.09 | 9.5 ± 0.4 | 1.9 ± 0.1 | 0.2 ± 0.02 | 17.0 ± 1.3 | 2.3 ± 0.2 | 0.1 ± 0.02 | 12.0 ± 0.9 | 2.2 ± 0.2 | 0.2 ± 0.02 |
FNsACP | 8.4 ± 0.8 | 2.2 ± 0.08 | 0.3 ± 0.03 | 8.3 ± 0.8 | 2.1 ± 0.4 | 0.3 ± 0.07 | 14.1 ± 1.4 | 1.5 ± 0.07 | 0.1 ± 0.02 | 10.9 ± 0.5 | 2.4 ± 0.05 | 0.2 ± 0.01 |
AprACP | 7.8 ± 0.8 | 14.3 ± 0.8 | 1.8 ± 0.3 | 9.1 ± 1.4 | 10.4 ± 0.8 | 1.1 ± 0.3 | 12.9 ± 2.1 | 13.1 ± 1.2 | 1.0 ± 0.2 | 9.0 ± 1.0 | 2.9 ± 0.1 | 0.3 ± 0.05 |
aThe data represented mean ± SD of three independent experiments; bUnits of K m, k cat, and k cat/K m are µM, min−1, and µM−1 min−1, respectively; cNo detectable activity.
Among the selected PPTases, APPT demonstrated the highest catalytic efficiencies toward AprACP, AFACP and APACP (1. 6 to 1.8 µM−1 min−1) (Table 1). These three cyanobacterial substrates were also favored by MPPT and SPPT (k cat/K m ≥ 1.0 µM−1 min−1). The catalytic efficiencies of APPT, MPPT and SPPT toward other cyanobacterial substrates were varied but both FisPCP and FNsACP were clearly disfavored (k cat/K m = 0.1 to 0.3 µM−1 min−1). Of note, we discovered that cognate CP/PPTase pairs generally demonstrate high catalytic efficiencies (k cat/K m ≥ 0.9 µM−1 min−1, e.g., MACP/MPPT), likely indicating the potential co-evolution of biosynthetic enzymes.
The K m values of four PPTases toward 11 CPs were in the µM range (Table 1). SFACP showed relatively tight interactions with all PPTases (K m = 1.5 to 3.2 µM), while APACP was a relatively weak binder (K m = 10.0 to 26.5 µM). Conversely, the PPTases showed the higher activity toward APACP (k cat ≥ 14.6 ± 1.3 min−1) compared to SFACP (k cat ≤ 2.2 ± 0.1 min−1). Interestingly, CP substrates demonstrated the lowest K m values toward their cognate PPTases in comparison with other enzymes, indicating the potential co-evolution. In this regard, SPPT showed higher K m values toward the majority of noncognate CPs than APPT and MPPT, presumably because of the lack of any PK or NRP cluster in Synechocystis. In line with this observation, the interactions of Sfp with the majority of cyanobacterial CPs were also relatively weak.
In vivo and in vitro activity of transiently expressed APPT, MPPT and Sfp in Synechocystis
To explore the in vivo catalytic performance of APPT, MPPT and Sfp, we chromosomally replaced the SPPT gene, the only known PPTase gene in Synechocystis, with their genes (Figs S7 and S8). The expression of the integrated PPTase genes was controlled by a constitutive strong promoter Ptrc40. After homologous recombination and multiple rounds of segregation, three stable Synechocystis mutants were identified by the PCR diagnosis as the loss of the SPPT gene and the presence of foreign PPTase gene (Fig. S8A). The transcription of these PPTase genes was confirmed in RT-PCR analysis (Fig. S8B). Furthermore, their transcription levels were quantitated in qRT-PCR analysis after being normalized with that of the rnpB gene encoding the RNA subunit of RNase P in each engineered strain and wild type. This analysis found that the transcriptional levels of the foreign PPTase genes in the mutants are five to six times higher than that of SPPT in the wild type (Fig. 4A). Importantly, the growth curve of the three mutant strains closely resembled the wild type over the entire 13-day culturing period (Fig. 4B). This data indicates the in vivo function of APPT, MPPT and Sfp as activating SFACP for the synthesis of essential FAs. To further evaluate the catalytic performance of these enzymes transiently expressed in cyanobacteria, we employed the soluble cell lysates of three Synechocystis mutants to functionalize all CP substrates except SFACP. LC-MS analysis detected the holo-products from all 30 reactions that were incubated for 16 hours (Fig. 5). The relatively long reaction time is likely caused by the low concentrations of recombinant proteins from the cyanobacterial expression system41. A high-copy self-replicating vector can potentially alleviate this issue42. Similar to an early report27, our attempts to create a Synechocystis ΔSPPT mutant failed, which further indicates the indispensability of a functional PPTase to fatty acid synthesis. Nonetheless, these in vitro results confirmed the catalytic functions of APPT, MPPT and Sfp expressed in Synechocystis mutants. The three Synechocystis mutants can be useful for the heterologous production of various cyanobacterial PKs, NRPs, and their hybrids.
Conclusions
PPTases are essential enzymes of all three domains of life as they functionalize CPs of FASs, PKSs, and NRPSs. The past two decades have witnessed significant advances of PPTase research, particularly about structure-function-relationship and biotechnological and biomedical applications19. Here, we characterized the phylogenetic relationships of cyanobacterial PPTases and then rationally selected six Sfp-like cyanobacterial enzymes along with Sfp to characterize their substrate scope and catalytic activity toward 11 CPs of FASs, PKSs, and NRPSs from cyanobacteria and Streptomyces strains. APPT, MPPT and Sfp demonstrated high catalytic activity and kinetic performance toward the majority of cyanobacterial CPs. Interestingly, PPTases favored cognate CP substrates in their reactions, suggesting the use of proper (e.g., cognate) PPTase for the heterologous production of natural products. This work used standalone CP substrates to characterize the catalytic performance of PPTases and previous studies suggest that they can demonstrate similar activity profiles toward CP domains within intact NRPS, PKS or their hybrids43,44. Furthermore, the validated in vivo and in vitro functions of transiently expressed APPT, MPPT and Sfp in the Synechocystis mutants suggest the availability of the novel, capable cyanobacterial synthetic biology chassis for the production of primary and secondary metabolites of cyanobacteria.
Electronic supplementary material
Acknowledgements
We thank Prof. CP Wolk (Michigan State University) for the gift of Anabaena sp. PCC7120. We also thank Drs Steven D Bruner, Valerie Paul and Valerie de Crécy-Lagard for informative discussions and Drs Ranjala Ratnayake, Dimitris Kallifidas and Andrew Hanson for technical support. Part of this work was supported by America Cancer Society-Institutional Research Grant (Y.D.) and the Department of Medicinal Chemistry at the University of Florida. Y.D. is an Air Force Office of Scientific Research Young Investigator.
Author Contributions
G.Y. and Y.D. conceived and designed experiments. G.Y. performed all major experiments, while Y.Z., N.K.L., M.A.C., and S.E.K. provided additional experimental assistance. G.Y., H.L. and Y.Z. wrote the manuscript. All authors critically reviewed the paper.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Electronic supplementary material
Supplementary information accompanies this paper at 10.1038/s41598-017-12244-3.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Mo S, Krunic A, Chlipala G, Orjala J. Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. J. Nat. Prod. 2009;72:894. doi: 10.1021/np800751j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dittmann E, Gugger M, Sivonen K, Fewer DP. Natural product biosynthetic diversity and comparative genomics of the cyanobacteria. Trends Microbiol. 2015;23:642–652. doi: 10.1016/j.tim.2015.07.008. [DOI] [PubMed] [Google Scholar]
- 3.Burja AM, Banaigs B, Abou-Mansour E, Burgess JG, Wright PC. Marine cyanobacteria-a prolific source of natural products. Tetrahedron. 2001;57:9347–9377. doi: 10.1016/S0040-4020(01)00931-0. [DOI] [Google Scholar]
- 4.Tan LT. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry. 2007;68:954–979. doi: 10.1016/j.phytochem.2007.01.012. [DOI] [PubMed] [Google Scholar]
- 5.Singh RK, Tiwari SP, Rai AK, Mohapatra TM. Cyanobacteria: an emerging source for drug discovery. J. Antibiot. 2011;64:401–412. doi: 10.1038/ja.2011.21. [DOI] [PubMed] [Google Scholar]
- 6.Martins A, Vieira H, Gaspar H, Santos S. Marketed marine natural products in the pharmaceutical and cosmeceutical industries: Tips for success. Mar. Drugs. 2014;12:1066–1101. doi: 10.3390/md12021066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Luesch H, Harrigan G, Goetz G, Horgen F. The cyanobacterial origin of potent anticancer agents originally isolated from sea hares. Curr. Med. Chem. 2002;9:1791–1806. doi: 10.2174/0929867023369051. [DOI] [PubMed] [Google Scholar]
- 8.Shih PM, et al. Improving the coverage of the cyanobacterial phylum using diversity-driven genome sequencing. Proc. Natl. Acad. Sci. USA. 2013;110:1053–1058. doi: 10.1073/pnas.1217107110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Leao T, et al. Comparative genomics uncovers the prolific and distinctive metabolic potential of the cyanobacterial genus. Moorea. Proc. Natl. Acad. Sci. USA. 2017;114:3198–3203. doi: 10.1073/pnas.1618556114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wenzel SC, Müller R. Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways. Curr. Opin. Biotechnol. 2005;16:594–606. doi: 10.1016/j.copbio.2005.10.001. [DOI] [PubMed] [Google Scholar]
- 11.Luo Y, Enghiad B, Zhao H. New tools for reconstruction and heterologous expression of natural product biosynthetic gene clusters. Nat. Prod. Rep. 2016;33:174–182. doi: 10.1039/C5NP00085H. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Li B, et al. Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc. Natl. Acad. Sci. USA. 2010;107:10430–10435. doi: 10.1073/pnas.0913677107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tianero MDB, Donia MS, Young TS, Schultz PG, Schmidt EW. Ribosomal route to small-molecule diversity. J. Am. Chem. Soc. 2011;134:418–425. doi: 10.1021/ja208278k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kim EJ, et al. Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product. Org. Lett. 2012;14:5824–5827. doi: 10.1021/ol302575h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jones AC, et al. Evaluation of Streptomyces coelicolor A3 (2) as a heterologous expression host for the cyanobacterial protein kinase C activator lyngbyatoxin A. FEBS J. 2012;279:1243–1251. doi: 10.1111/j.1742-4658.2012.08517.x. [DOI] [PubMed] [Google Scholar]
- 16.Ongley SE, et al. High-titer heterologous production in E. coli of lyngbyatoxin, a protein kinase C activator from an uncultured marine cyanobacterium. ACS Chem. Biol. 2013;8:1888–1893. doi: 10.1021/cb400189j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Videau P, Wells KN, Singh AJ, Gerwick WH, Philmus B. Assessment of Anabaena sp. strain PCC 7120 as a heterologous expression host for cyanobacterial natural products: production of lyngbyatoxin a. ACS Synth. Biol. 2016;5:978–988. doi: 10.1021/acssynbio.6b00038. [DOI] [PubMed] [Google Scholar]
- 18.Lambalot RH, et al. A new enzyme superfamily - the phosphopantetheinyl transferases. Chem. Biol. 1996;3:923–936. doi: 10.1016/S1074-5521(96)90181-7. [DOI] [PubMed] [Google Scholar]
- 19.Beld J, Sonnenschein EC, Vickery CR, Noel JP, Burkart MD. The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life. Nat. Prod. Rep. 2014;31:61–108. doi: 10.1039/C3NP70054B. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Elovson J, Vagelos PR. Acyl carrier protein. X. Acyl carrier protein synthetase. J. Biol. Chem. 1968;243:3603–3611. [PubMed] [Google Scholar]
- 21.Quadri LEN, et al. Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry. 1998;37:1585–1595. doi: 10.1021/bi9719861. [DOI] [PubMed] [Google Scholar]
- 22.Copp JN, Neilan BA. The phosphopantetheinyl transferase superfamily: phylogenetic analysis and functional implications in cyanobacteria. Appl. Environ. Microbiol. 2006;72:2298–2305. doi: 10.1128/AEM.72.4.2298-2305.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hopwood, D. A. Complex enzymes in microbial natural product biosynthesis, Part A: overview articles and peptides. Vol. 458 (Academic Press, 2009).
- 24.Lambalot RH, Walsh CT. Holo-[acyl-carrier-protein] synthase of Escherichia coli. Methods Enzymol. 1997;279:254–262. doi: 10.1016/S0076-6879(97)79029-3. [DOI] [PubMed] [Google Scholar]
- 25.George N, Pick H, Vogel H, Johnsson N, Johnsson K. Specific labeling of cell surface proteins with chemically diverse compounds. J. Am. Chem. Soc. 2004;126:8896–8897. doi: 10.1021/ja048396s. [DOI] [PubMed] [Google Scholar]
- 26.Copp J, Roberts A, Marahiel M, Neilan B. Characterization of PPTNs, a cyanobacterial phosphopantetheinyl transferase from Nodularia spumigena NSOR10. J. Bacteriol. 2007;189:3133–3139. doi: 10.1128/JB.01850-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Roberts AA, Copp JN, Marahiel MA, Neilan BA. The Synechocystis sp. PCC6803 Sfp-type phosphopantetheinyl transferase does not possess characteristic broad-range activity. ChemBioChem. 2009;10:1869–1877. doi: 10.1002/cbic.200900095. [DOI] [PubMed] [Google Scholar]
- 28.Méjean A, et al. In vitro reconstitution of the first steps of anatoxin-a biosynthesis in Oscillatoria PCC 6506: from free L-proline to acyl carrier protein bound dehydroproline. Biochemistry. 2009;49:103–113. doi: 10.1021/bi9018785. [DOI] [PubMed] [Google Scholar]
- 29.Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science. 2001;291:1790–1792. doi: 10.1126/science.1058092. [DOI] [PubMed] [Google Scholar]
- 30.Gu L, et al. Metamorphic enzyme assembly in polyketide diversification. Nature. 2009;459:731–735. doi: 10.1038/nature07870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ding Y, Rath CM, Bolduc KL, Hakansson K, Sherman DH. Chemoenzymatic synthesis of cryptophycin anticancer agents by an ester bond-forming non-ribosomal peptide synthetase module. J. Am. Chem. Soc. 2011;133:14492–14495. doi: 10.1021/ja204716f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016;33:1870–1874. doi: 10.1093/molbev/msw054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Rippka R, Deruelles J, Waterbury JB, Herdman M, Stanier RY. Generic assignments, strain histories and properties of pure cultures of cyanobacteria. Microbiology. 1979;111:1–61. doi: 10.1099/00221287-111-1-1. [DOI] [Google Scholar]
- 34.Kaneko T, et al. Complete genomic structure of the bloom-forming toxic cyanobacterium Microcystis aeruginosa NIES-843. DNA Res. 2007;14:247–256. doi: 10.1093/dnares/dsm026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Campbell EL, Cohen MF, Meeks JC. A polyketide-synthase-like gene is involved in the synthesis of heterocyst glycolipids in Nostoc punctiforme strain ATCC 29133. Arch. Microbiol. 1997;167:251–258. doi: 10.1007/s002030050440. [DOI] [PubMed] [Google Scholar]
- 36.Balskus EP, Walsh CT. The genetic and molecular basis for sunscreen biosynthesis in cyanobacteria. Science. 2010;329:1653–1656. doi: 10.1126/science.1193637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Barry SM, et al. Cytochrome P450–catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis. Nat. Chem. Biol. 2012;8:814–816. doi: 10.1038/nchembio.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Walsh TA, et al. Canola engineered with a microalgal polyketide synthase-like system produces oil enriched in docosahexaenoic acid. Nat. Biotechnol. 2016;34:881–887. doi: 10.1038/nbt.3585. [DOI] [PubMed] [Google Scholar]
- 39.Mootz HD, Finking R, Marahiel MA. 4′-Phosphopantetheine transfer in primary and secondary metabolism of Bacillus subtilis. J. Biol. Chem. 2001;276:37289–37298. doi: 10.1074/jbc.M103556200. [DOI] [PubMed] [Google Scholar]
- 40.Huang HH, Camsund D, Lindblad P, Heidorn T. Design and characterization of molecular tools for a synthetic biology approach towards developing cyanobacterial biotechnology. Nucleic Acids Res. 2010;38:2577–2593. doi: 10.1093/nar/gkq164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Guerrero, F., Carbonell, V., Cossu, M., Correddu, D. & Jones, P. R. Ethylene synthesis and regulated expression of recombinant protein in Synechocystis sp. PCC 6803. PLoS One7, doi:10.1371/journal.pone.0050470 (2012). [DOI] [PMC free article] [PubMed]
- 42.Xue Y, Zhang Y, Cheng D, Daddy S, He Q. Genetically engineering Synechocystis sp. Pasteur Culture Collection 6803 for the sustainable production of the plant secondary metabolite p-coumaric acid. Proc. Natl. Acad. Sci. USA. 2014;111:9449–9454. doi: 10.1073/pnas.1323725111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Weissman KJ, Hong H, Oliynyk M, Siskos AP, Leadlay PF. Identification of a phosphopantetheinyl transferase for erythromycin biosynthesis in Saccharopolyspora erythraea. ChemBioChem. 2004;5:116–125. doi: 10.1002/cbic.200300775. [DOI] [PubMed] [Google Scholar]
- 44.Pavlidou M, et al. The phosphopantetheinyl transferase KirP activates the ACP and PCP domains of the kirromycin NRPS/PKS of Streptomyces collinus Tü 365. FEMS Microbiol. Lett. 2011;319:26–33. doi: 10.1111/j.1574-6968.2011.02263.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data generated or analyzed during this study are included in this manuscript (and its Supplementary Information files).